Cargando…
Autoantibodies against a 43 KDa Muscle Protein in Inclusion Body Myositis
BACKGROUND: Inclusion body myositis (IBM) is a poorly understood and refractory autoimmune muscle disease. Though widely believed to have no significant humoral autoimmunity, we sought to identify novel autoantibodies with high specificity for this disease. METHODOLOGY/PRINCIPAL FINDINGS: Plasma aut...
Autores principales: | Salajegheh, Mohammad, Lam, Theresa, Greenberg, Steven A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3100335/ https://www.ncbi.nlm.nih.gov/pubmed/21629782 http://dx.doi.org/10.1371/journal.pone.0020266 |
Ejemplares similares
-
Association Between TDP-43 and Mitochondria in Inclusion Body Myositis
por: Huntley, Mikayla L., et al.
Publicado: (2019) -
Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis
por: Dalakas, Marinos C., et al.
Publicado: (2009) -
Anti-NT5c1A Autoantibodies as Biomarkers in Inclusion Body Myositis
por: Amlani, Adam, et al.
Publicado: (2019) -
HLA-DRB1 allele and autoantibody profiles in Japanese patients with inclusion body myositis
por: Oyama, Munenori, et al.
Publicado: (2020) -
Widespread RNA metabolism impairment in sporadic inclusion body myositis TDP43-proteinopathy()
por: Cortese, Andrea, et al.
Publicado: (2014)